RNU6-749P

Across TCGA pan-cancer cohorts, RNU6-749P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-749P data layer.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher RNU6-749P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-749P expression acts as an unfavorable survival marker.

GBM, COAD, and PRAD are the cancer types where RNU6-749P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	OS	Tertile	All	0.089	0.413	.023	18	view →
COAD	OS	Tertile	All	0.312	0.806	.039	18	view →
PRAD	DFS	Tertile	All	0.118	0.886	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNU6-749P–GBM (OS)

Open the GBM breakdown →